Adicet Bio Inc. (ACET) |
|
13.15 -1.41 (-9.68%)
|
01-19 08:44 |
|
Open: |
14.41 |
Pre. Close: |
14.56 |
|
High:
|
14.4699 |
Low:
|
13.09 |
|
Volume:
|
329,452 |
Market Cap:
|
515M |
|
|
|
|
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase 1 clinical study for the treatment of non-Hodgkin's lymphoma. The company also engages in the development of ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors, including hepatocellular carcinoma, gastric cancer, and squamous cell carcinoma of the lung. The company is based in Boston, Massachusetts. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
14.483 - 14.585 |
14.585 - 14.664 |
|
Low:
|
12.913 - 13.014 |
13.014 - 13.091 |
|
Close:
|
13.021 - 13.174 |
13.174 - 13.293 |
|
Technical analysis |
as of: 2022-01-19 8:18:56 AM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 19.11 One year: 21.60 |
| Support: |
Support1: 12.92 Support2: 10.75 |
| Resistance: |
Resistance1: 16.36 Resistance2: 18.49 |
| Pivot: |
15.60  |
| Moving Average: |
MA(5): 14.00 MA(20): 15.65
MA(100): 10.56  MA(250): 11.38 |
| MACD: |
MACD(12,26): 0.08 Signal(9): 0.65 |
| Stochastic oscillator: |
%K(14,3): 7.56 %D(3): 8.51 |
| RSI: |
RSI(14): 41.32 |
| 52-week: |
High: 18.49 Low: 6.25 Change(%): -10.5 |
| Average Vol(K): |
3-Month: 124147 10-Days: 31701 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.ACET has closed above bottom band by 8.3%. Bollinger Bands are 103% wider than normal. The large width of the bands suggest high volatility as compared to ACET's normal range. The bands have been in this wide range for 3 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Tue, 04 Jan 2022
Short Interest in Adicet Bio, Inc. (NASDAQ:ACET) Rises By 258.3% - MarketBeat
Mon, 03 Jan 2022
3 Biotech Stocks That Could Double in 2022 - Nasdaq
Sat, 01 Jan 2022
What Type Of Shareholders Make Up Adicet Bio, Inc.'s (NASDAQ:ACET) Share Registry? - Nasdaq
Wed, 08 Dec 2021
Adicet Bio, Inc. Announces Pricing of Public Offering of Common Stock - GlobeNewswire
Mon, 06 Dec 2021
Why Adicet Bio Stock Is Skyrocketing Today - Motley Fool
Mon, 08 Nov 2021
Adicet Bio to Participate in Stifel 2021 Virtual Healthcare Conference - Yahoo Finance
|
Financial Analysis |
| Growth |
NA |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
NA |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
NA |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
NA |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Neutral |
Price to Earnings: |
Underperform |
| Return on Equity: |
Neutral |
Debt to Equity: |
Neutral |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Basic Materials |
| Industry: Biotechnology |
| Shares Out. (M) |
39 |
| Shares Float (M) |
13 |
|
% Held by Insiders
|
11.42 |
|
% Held by Institutions
|
60.94 |
|
Shares Short (K)
|
910 |
|
Shares Short P. Month (K)
|
301 |
Stock Financials |
|
EPS
|
-2.010 |
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
6.800 |
|
Profit Margin
|
|
|
Operating Margin
|
-474.05 |
|
Return on Assets (ttm)
|
-14.1 |
|
Return on Equity (ttm)
|
-33.0 |
|
Qtrly Rev. Growth
|
13.2 |
|
Gross Profit (p.s.)
|
0.457 |
|
Sales Per Share
|
0.247 |
|
EBITDA (p.s.)
|
-1.133 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-51 |
|
Levered Free Cash Flow (M)
|
-36 |
Stock Valuations |
|
PE Ratio
|
-6.54 |
|
PEG Ratio
|
|
|
Price to Book value
|
1.93 |
|
Price to Sales
|
53.22 |
|
Price to Cash Flow
|
-10.10 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
2020-09-15 |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
